Secondary Logo

Journal Logo

Takotsubo (Stress) Cardiomyopathy and the Anesthesiologist: Enough Case Reports. Let's Try to Answer Some Specific Questions!

Hessel, Eugene A. II MD*; London, Martin J. MD

doi: 10.1213/ANE.0b013e3181c9fa22
Editorials: Editorials
Free
SDC

From the *Department of Anesthesiology, University of Kentucky College of Medicine, Lexington, Kentucky; and †Department of Anesthesia and Perioperative Care, University of California, San Francisco, San Francisco, California.

Accepted for publication October 23, 2009.

Supported by institutional funds.

Address correspondence to Eugene A. Hessel, II, MD, Department of Anesthesiology, 800 Rose St., Lexington, KY 40536-0293. Address e-mail to ehessel@uky.edu.

Takotsubo cardiomyopathy (also known as takotsubo syndrome, broken heart syndrome, ampulla cardiomyopathy, transient left ventricular apical ballooning, apical ballooning syndrome, transient left ventricular dysfunction syndrome, and stress [induced] cardiomyopathy) was first described in Japan in 1990.1** It was initially characterized by a unique pattern of transient (hours to weeks) wall motion abnormality (“transient left ventricular apical ballooning”) occurring in the absence of significant epicardial coronary artery disease, presenting as an acute coronary syndrome, most frequently in postmenopausal elderly women, often triggered by stressful situations. It has since been observed throughout the world and under various circumstances.†† This condition was first described in the perioperative period in the North American anesthesia literature via case reports that appeared in the September 2006 issues of Anesthesia & Analgesia4 and Anesthesiology.5 Since that time, multiple case reports of periprocedural (e.g., endoscopy, catheterization, and electroconvulsive therapy) and at least 25 to 38 perioperative cases of takotsubo cardiomyopathy have appeared6–23 with the latest in this issue of Anesthesia & Analgesia.24,25 Anesthesiologists may also confront this syndrome while caring for patients with aneurysmal subarachnoid hemorrhage (A-SAH),26–29 pheochromocytoma,30–37 and other critical illnesses.3,38,39

In this issue of Anesthesia & Analgesia, Daly and Dixon24 report on 2 cases of takotsubo cardiomyopathy that occurred in an elderly (76- and 78-year-old) man and woman, which the authors attribute to severe peri-injury pain. Wong et al.25 report on a case presenting immediately preoperatively in a 63-year-old woman scheduled to undergo elective minor surgery. Notably, none of these patients presented with chest pain or dyspnea, but rather with electrocardiographic (ECG) changes (with or without elevated cardiac enzymes). All 3 recovered from the acute phase of this syndrome without complications with supportive management (β-adrenergic blockade, angiotensin-converting enzyme inhibitors, statins, and heparin, with or without clopidogrel) and tolerated subsequent surgery without problems. Both sets of authors have nicely reviewed various aspects of this syndrome, but these case reports raise additional important questions of obvious interest to anesthesiologists. Why did these patients develop this syndrome in the face of an apparent amount of pain or perioperative anxiety that would not be expected to cause cardiac injury in most patients? Is there something unique about pain or how some patients process pain that contributes to the pathogenesis of this syndrome? What is the true incidence of this syndrome during the perioperative period? The authors suggest that it is rare, but is it actually? Why is this syndrome now being reported so frequently (i.e., in this decade)? Was it just missed previously (perhaps because of less-frequent “routine” perioperative use of echocardiography) or has something changed in our clinical environment or patient populations or how we care for them that explains its recent occurrence? Did the perioperative management of these patients (β-adrenergic blockade, aspirin, statins, heparin, with or without clopidogrel) contribute to their recovery or would it have occurred without these therapies? What is the optimal anesthetic management of patients who have recently or remotely experienced takotsubo syndrome?

It is now abundantly clear that the observation that takotsubo cardiomyopathy occurs in the perioperative period is no longer unique and therefore further case reports, particularly those that focus on the “basics” of this syndrome, are not likely to help advance our understanding of the condition. Thus, it is highly unlikely that this journal will publish any case reports in the future on its isolated occurrence in 1 or 2 patients, as have been described by Daly and Dixon and Wong et al., unless they provide completely unique insights or are able to provide objective quantitative measurement of factors related to the development of this syndrome (e.g., myocardial catecholamine receptors in an autopsy specimen). As discussed below, it is obvious that what is needed are more specialized or complex approaches that address the many unresolved questions listed above. These range from detailed biochemical/pharmacogenomic approaches to more sophisticated epidemiologic approaches (e.g., case registries to accumulate large numbers of patients).

Given that the recent “surge” of information on this syndrome is spread among so many diverse journals, we herein summarize what is known and identify important questions yet to be answered, based on the data presented by the case reports of Daly and Dixon24 and Wong et al.,25 recent systematic40–44 and other review articles and commentaries,2,45–58 and a number of case series.59–74 Finally, we present our suggestions for answering these remaining questions.

Back to Top | Article Outline

WHAT IS KNOWN?

Bybee and Prasad3 have reviewed the various stress-related cardiomyopathy syndromes, which they describe as occurring in several different contexts: (1) classic takotsubo cardiomyopathy, which presents as an acute coronary syndrome, (2) left ventricular dysfunction associated with acute intracranial disease, especially A-SAH, (3) transient cardiomyopathy, which occurs during other critical illness, especially sepsis, and (4) transient cardiomyopathy associated with pheochromocytoma and exogenous catecholamine administration. Whether in fact these categories represent a spectrum of the same syndrome is not definitely known but is quite likely.

In several large series, about 13% (6%–16%) of cases occurred perioperatively, periprocedurally, or were associated with fractures.59,60,67,74 Although the classic pattern of wall motion abnormality observed is hypokinesia or dyskinesia of the distal mid and apical walls of the left ventricle (“apical ballooning”), usually associated with hyperkinesia of the basal segments, several other patterns (described as “variants”) have been reported including isolated midventricular and even basilar (so-called “inverted takotsubo”) hypokinesis. Thus, the apical ballooning pattern is no longer considered pathognomonic of the syndrome. Whether the pattern of transient global hypokinesia can be included in this syndrome has not been clarified. Although its onset is often preceded/precipitated by emotional or physiologic stress (between 45% and 85% of the time), this is not invariable. Furthermore, the onset of the stress may have preceded the presentation by several days, and often, the degree of stress does not seem to be unusual.

As discussed by Daly and Dixon24 and Wong et al.,25 the most commonly accepted cause is excessive adrenergic/catecholamine stimulation, which damages cardiomyocytes75 (Fig. 1). Recent reports of its acute precipitation by administration of catecholamines (epinephrine or dobutamine),76,77 its occurrence in patients with pheochromocytoma,32 and its reproduction by infusion of epinephrine in primates78 strongly support this hypothesis. Other case reports have described transient global ventricular dysfunction associated with chest pain, ECG changes, and often troponin release after epinephrine administration (8, 0.75, and 0.1 mg, respectively).79–81 Suk et al.82 recently described a 32-year-old woman who developed the midventricular variant of takotsubo syndrome after anaphylactic shock during general anesthesia, which had been treated with epinephrine (1 mg) before onset of the syndrome, whereas Zubrinich et al.83 reported the occurrence of the classic syndrome in a 76-year-old woman after administration of epinephrine (0.3 mg) via an “EpiPen” for lip angioedema. Interestingly, this patient was receiving chronic treatment with a nonselective β-adrenergic blocker (oxprenolol) at the time. Han and Yeon84 reported a case of probable midventricular variant of takotsubo cardiomyopathy in a 41-year-old man after anaphylaxis treated with epinephrine (0.2 mg). The role of therapeutically administered epinephrine versus sympathetic activation (with catecholamine release) or other mediators precipitated by anaphylaxis per se is conjectural. However, a report by Vultaggio et al.85 of the occurrence of classic takotsubo syndrome in a young woman after anaphylaxis, who did not receive epinephrine, suggests that the former is not essential in the pathogenesis of this syndrome. Finally, as mentioned by Daly and Dixon24 and Wong et al.,25 other factors besides catecholamines may be involved exclusively or additively in the pathogenesis of this syndrome in some patients including transient epicardial coronary thrombosis, coronary artery spasm, coronary microvascular dysfunction, and dynamic left ventricular outflow tract obstruction.

Figure 1

Figure 1

Although takotsubo syndrome classically presents with chest pain, dyspnea, and ECG changes, these findings are not invariably present. It is interesting that none of the 3 patients reported by Daly and Dixon24 and Wong et al.25 complained of chest pain (which perhaps was masked by their somatic pain from injury in the former report). This resembles the situation in the majority of cases of perioperative myocardial infarction.86 Other authors have suggested that dyspnea may be a more common presentation in African American women.87,88 The age (62–75 years) and gender predominance (about 80%–100% postmenopausal women) encountered in classic takotsubo syndrome may be less obvious in the variant forms in which patients often are younger and more often male.

Although most patients recover without complications after an episode of takotsubo cardiomyopathy, serious complications including congestive heart failure (occurring in as many as 44%–57% of patients),63,67 pulmonary edema often requiring endotracheal intubation and mechanical ventilation, and cardiogenic shock (15%–45% of cases) requiring vasopressor or inotropic therapy27,45,50,60,71,74 and even intraaortic balloon pumping45,50,53,55,60,66,67,71,72,74 do occur. Other complications such as ventricular arrhythmias including torsade de pointes,63,67,89 syncope, cardiac arrest, apical thrombosis, and thromboembolism including stroke, dynamic intraventricular gradients, and obstruction (up to 25%)64 with or without systolic anterior motion of the mitral valve, severe mitral regurgitation, ruptured ventricle, and death (1%–3% but as high as 21%)63 have been reported.55,68,74 Elesber et al.67 at the Mayo Clinic observed a recurrence rate of 11.4% over an average follow-up of 4.4 ± 4.6 years of 100 patients with takotsubo cardiomyopathy (2.9% per year over the first 4 years and 1.3% per year thereafter). Interestingly, only 2 of the 10 patients who experienced a recurrence had an identifiable precipitating event at that time.

Back to Top | Article Outline

WHAT IS NOT KNOWN?

As noted above, there is no clear explanation for individual susceptibility to takotsubo cardiomyopathy after exposure to a similar degree of emotional or physiologic stress or dose of exogenous catecholamines that usually do not adversely affect most patients. It is not improbable that genetic heterogeneity of the adrenergic receptors, rendering them more or less sensitive to adrenergic stimuli, may explain some of this variability as has been shown for the neurocardiac injury associated with A-SAH90 and sensitivity to β-adrenergic blocking drugs,91,92 but not yet in takotsubo cardiomyopathy.93 Furthermore, the cause or trigger in individuals who develop the syndrome in the absence of an obvious emotional/physiologic stressor is not clear.

Although various hypotheses have been proposed, there is no established explanation for the susceptibility of elderly women to this condition or why particular myocardial segments are prone to dysfunction when this cardiomyopathy occurs.

Finally, optimal therapy during the acute phase and after the patient has recovered, especially in the perioperative period, is yet to be defined. Because of the presumed role of excess catecholamines in its pathogeneses, avoidance of adrenergic agonists and initiation of antiadrenergic therapy (e.g., β-adrenergic blocking drugs or centrally acting α2 agonists) have been advocated. Clearly, therapy must be individualized based on the clinical presentation. In patients presenting with left ventricular outflow tract obstruction,94 catecholamines are particularly contraindicated. However, it is unclear whether the administration of inotropic drugs to treat systolic dysfunction (heart failure, pulmonary edema, and cardiogenic shock) is harmful (i.e., does it worsen the transiently dysfunctional myocardium or impair full recovery?). And, if inotropic support is needed, is there an inotrope of choice? Padayachee95 suggests that the calcium sensitizer levosimendan may be the best choice. Are there therapies that hasten recovery? A recent primate study suggests that administration of metoprolol after development of epinephrine-induced cardiomyopathy hastens recovery.78 Mechanical support of the circulation (e.g., intraaortic balloon pump and ventricular assist device) is clearly an option to avoid catecholamine use, but not without significant risk for additional complications related to these devices.45,50,53,55,60,66,67,71,72,74

From our review of the literature, it seems likely, but has not been conclusively proven, that a substantial portion of the damage caused by catecholamine toxicity to the myocardium has likely occurred by the time of clinical presentation, and thus administration of antiadrenergic therapy at this time is unlikely to completely reverse injury. Indeed, in a number of reported cases, catecholamines seem to have facilitated recovery in patients with acute left ventricular dysfunction.27,45,50,60,71,74 As in the setting of acute myocardial infarction with significant systolic dysfunction, routine early administration of β-adrenergic blockers may be potentially hazardous, potentially leading to cardiogenic shock.96

How to best prevent perioperative takotsubo cardiomyopathy and whether there is a best anesthetic technique to use in patients who have experienced the syndrome previously (remotely or recently) who now require surgery is unclear. The role of β-blocker therapy in managing these patients is unclear because the dose necessary to block the excessive levels of catecholamines that may precipitate takotsubo cardiomyopathy might not be hemodynamically tolerated. However, it is also likely that a certain percentage of patients who are unusually sensitive to catecholamines will be responsive to prophylactic β-blocker therapy. The possible futility of prophylactic β-blocker therapy is reinforced by the aforementioned case report by Zubrinich83 and by the observation that 26% of the patients in the Rhode Island Registry had been taking β-adrenergic receptor blockers at the time they presented with the syndrome.59 However, abrupt β-adrenergic blocker withdrawal was hypothesized to be the cause of takotsubo cardiomyopathy in a case report of a 56-year-old woman.97 Given the intense interest in the benefits and risks of perioperative β-blockade in prevention of cardiac complications, this is an area in which additional clinical information would be particularly welcomed.

Back to Top | Article Outline

WHAT IS NEEDED TO TRY TO ANSWER THESE UNRESOLVED QUESTIONS?

  • 1. Additional case reports describing isolated occurrences of this syndrome unless they provide unique insights into previously undescribed etiology or pathophysiology associated with this syndrome would seem to be of little further value. Whatever term the clinician prefers to describe this syndrome and its variants, it is now a well established one in the perioperative setting.
  • 2. Large population cohort studies to identify/define the incidence, characteristics, and risk factors in perioperative populations, as recommended by Suk et al.,82 are of particular importance.
  • 3. Establishment of perioperative patient registries. The 2 major hospitals in Rhode Island have established such a registry to study all cases of takotsubo cardiomyopathy in that state.59 The anesthesia community is well aware of the registry established by the University of Washington to study perioperative optic ischemia, which has provided valuable information on this rare event. We call on enterprising individuals, institutions, or societies (e.g., Society of Cardiovascular Anesthesiologists and Anesthesia Patient Safety Foundation) to seriously consider the feasibility of establishing a perioperative takotsubo registry. Although it would likely be a logistically difficult endeavor, given the variability in presentation of this syndrome and similarities to other forms of acute coronary syndromes that may present with greater frequency perioperatively, we believe that the information to be gained could be substantial. Given the ongoing interest in prophylactic manipulation of the adrenergic nervous system perioperatively, finding adequate substrate on which to base focused clinical investigations of possible etiologic and pathophysiologic factors would be most important (e.g., pharmacogenomic evaluation of patients sustaining this syndrome).
  • 4. Genetic studies, especially as they relate to adrenergic receptors and their sensitivity to and release of catecholamines, are of particular interest.90–93
  • 5. There is clearly substantial similarity between classic takotsubo cardiomyopathy and the cardiac injury encountered in A-SAH including ECG changes (ST changes, T wave inversion, and prolonged QTc), relatively low levels of troponin release, and transient wall motion abnormalities (although the classic midapical ballooning pattern is less dominant, it has been well described with A-SAH).27,98 Because the latter form of stress cardiomyopathy seems to be more prevalent and more predictable than the sporadic perioperative syndrome, we believe that the characteristics and management strategies used to treat cardiac injury associated with A-SAH are likely directly applicable to perioperative takotsubo cardiomyopathy.

In summary, although it is infrequently encountered, takotsubo cardiomyopathy is now a well-established clinical syndrome reported in a variety of clinical settings. Given the abundance of case reports and small clinical series, clinicians working in the perioperative and critical care environments managing patients presenting with acute coronary syndromes, new onset of dyspnea, ECG evidence of myocardial ischemia, or left ventricular failure should be able to distinguish it from acute myocardial dysfunction caused by occlusive epicardial coronary events although most patients will require similar diagnostic testing to rule it in or out. The prognostic implications (e.g., generally more favorable) and therapeutic options (e.g., less clear) seem to be distinctly different. Intraoperative transesophageal echocardiography or perioperative transthoracic echocardiography provide valuable information to establish the diagnosis and guide appropriate hemodynamic therapy especially in the “classic” takotsubo wall motion pattern. We hope that the case reports of Daly and Dixon24 and Wong et al.25 presented in this issue of Anesthesia & Analgesia will be the last of their kind and that future efforts will tackle the considerably more difficult task of providing aggregate data on large groups of patients developing this syndrome or can provide detailed biochemical, physiologic, or pharmacogenomic data on specific patients currently absent from the literature base.

Back to Top | Article Outline

AUTHOR CONTRIBUTIONS

Both authors had essential roles in the conception of this editorial, examination of the literature, and preparing the manuscript and its revisions. This editorial reflects the opinions of both authors who have each reviewed and approved the final manuscript.

Back to Top | Article Outline

REFERENCES

1. Sato H, Tateishi H, Uchida T. Takotsubo-type cardiomyopathy due to multivessel spasm. In: Kodama K, Haze K, Hon M, eds. Clinical aspect of myocardial injury: from ischemia to heart failure [in Japanese]. Tokyo: Kagakuhyouronsha, 1990:56–64
2. Wittstein IS. Acute stress cardiomyopathy. Curr Heart Fail Rep 2008;5:61–8
3. Bybee KA, Prasad A. Stress-related cardiomyopathy syndromes. Circulation 2008;118:397–409
4. Lentschener C, Vignaux O, Spaulding C, Bonnichon P, Legmann P, Ozier Y. Early postoperative tako-tsubo-like left ventricular dysfunction transient left ventricular apical ballooning syndrome. Anesth Analg 2006;103:580–2
5. Gavish D, Rozenman Y, Hafner R, Bartov E, Ezri T. Takotsubo cardiomyopathy after general anesthesia for eye surgery. Anesthesiology 2006;105:621–3
6. Artukoglu F, Owen A, Hemmerling TM. Tako-Tsubo syndrome in an anaesthetised patient undergoing arthroscopic knee surgery. Ann Card Anaesth 2008;11:38–41
7. Liu S, Bravo-Fernandez C, Riedl C, Antapli M, Dhamee MS. Anesthetic management of Takotsubo cardiomyopathy: general versus regional anesthesia. J Cardiothorac Vasc Anesth 2008;22:438–41
8. Tiwari AK, D'Attellis N. Intraoperative left ventricular apical ballooning: transient takotsubo cardiomyopathy during orthotopic liver transplantation. J Cardiothorac Vasc Anesth 2008;22:442–5
9. Kogan A, Ghosh P, Schwammenthal E, Raanani E. Takotsubo syndrome after cardiac surgery. Ann Thorac Surg 2008;85: 1439–41
10. Cruvinel MG, Carneiro FS, Bessa RC Jr, Pereira e Silva Y, Marques MB. Tako-Tsubo syndrome secondary to residual neuromuscular blockade. Case report [in Portuguese]. Rev Bras Anestesiol 2008;58:626–30, 623–6
11. Consales G, Campiglia L, Michelagnoli G, Gallerani E, Rinaldi S, Del Pace S, De Gaudio AR. Acute left ventricular dysfunction due to Tako-tsubo syndrome after induction of general anesthesia. Minerva Anestesiol 2007;73:655–8
12. Jabaudon M, Bonnin M, Bolandard F, Chanseaume S, Dauphin C, Bazin JE. Takotsubo syndrome during induction of general anaesthesia. Anaesthesia 2007;62:519–23
13. Itoh H, Miyake Y, Hioki I, Tanaka S, Okabe M. Report of takotsubo cardiomyopathy occurring during cardiopulmonary bypass. J Extra Corpor Technol 2007;39:109–11
14. Wong CP, Jim MH, Chan AO, Chau EM, Chow WH. Iatrogenic Tako-Tsubo cardiomyopathy. Int J Cardiol 2008;125:e16–e18
15. Berman M, Saute M, Porat E, Vaturi M, Paul-Kislin L, Vidne BA, Kogan A. Takotsubo cardiomyopathy: expanding the differential diagnosis in cardiothoracic surgery. Ann Thorac Surg 2007;83:295–8
16. Lee HR, Hurst RT, Vargas HE. Transient left ventricular apical ballooning syndrome (Takotsubo cardiomyopathy) following orthotopic liver transplantation. Liver Transpl 2007;13:1343–5
17. Jensen JB, Malouf JF. Takotsubo cardiomyopathy following cholecystectomy: a poorly recognized cause of acute reversible left ventricular dysfunction. Int J Cardiol 2006;106:390–1
18. Rivera JM, Locketz AJ, Fritz KD, Horlocker TT, Lewallen DG, Prasad A, Bresnahan JF, Kinney MO. “Broken heart syndrome” after separation (from OxyContin). Mayo Clin Proc 2006;81:825–8
19. Ramakrishna G, Ravi BS, Chandrasekaran K. Apical ballooning syndrome in a postoperative patient with normal microvascular perfusion by myocardial contrast echocardiography. Echocardiography 2005;22:606–10
20. Chang KH, Ogawa M, Hanaoka K. Takotsubo-shaped cardiomyopathy manifesting as perioperative T-wave inversion [Letter to editor]. J Anesth 2004;18:65
21. Ide M, Esaki Y, Yamazaki K, Kato H. Newly developed T-wave inversion with cardiac wall-motion abnormality predominantly occurs in middle-aged or elderly women after noncardiac surgery. J Anesth 2003;17:79–83
22. Takigawa T, Tokioka H, Chikai T, Fukushima T, Ishizu T, Kosogabe Y. [A case of undiagnosed “takotsubo” cardiomyopathy during anesthesia] [in Japanese]. Masui 2003;52:1104–6
23. Mizutani K, Okada M. [A case of intraoperative repeated coronary artery spasm with ST-segment depression] [in Japanese]. Masui 2002;51:1114–6
24. Daly MJ, Dixon LJ. Takotsubo cardiomyopathy in preoperative patients with pain. Anesth Analg 2010;110:708–11
25. Wong AK, Vernik WJ, Wiegers SE, Howell JA, Sinha AC. Perioperative Takotsubo cardiomyopathy identified in the operating room prior to induction of anesthesia. Anesth Analg 2010;110:712–5
26. Maréchaux S, Fornes P, Petit S, Poisson C, Thevenin D, Le Tourneau T, Asseman P, Bruneval P, Ennezat PV. Pathology of inverted Takotsubo cardiomyopathy. Cardiovasc Pathol 2008;17:241–3
27. Lee VH, Connolly HM, Fulgham JR, Manno EM, Brown RD Jr, Wijdicks EF. Tako-tsubo cardiomyopathy in aneurysmal subarachnoid hemorrhage: an underappreciated ventricular dysfunction. J Neurosurg 2006;105:264–70
28. Otomo S, Sugita M, Shimoda O, Terasaki H. Two cases of transient left ventricular apical ballooning syndrome associated with subarachnoid hemorrhage. Anesth Analg 2006;103:583–6
29. D'Aloia A, Vizzardi E, Faggiano P, Fiorina C, Cas LD. Intracranial bleeding mimicking an extensive acute myocardial infarction with reversible apical ballooning and systolic left ventricular dysfunction. A case report. Monaldi Arch Chest Dis 2007;68:44–7
30. Verrijcken A, Sciot R, Dubois CL. From trivial headache to life-threatening disease. Int J Cardiol. Epub ahead of print, January 25, 2009
31. Von Bergen NH, Lyon JK, Edens RE. Takotsubo-like cardiomyopathy in a 17-year-old male with a pheochromocytoma. Pediatr Cardiol 2009;30:184–7
32. Kassim TA, Clarke DD, Mai VQ, Clyde PW, Mohamed Shakir KM. Catecholamine-induced cardiomyopathy. Endocr Pract 2008;14:1137–49
33. Zegdi R, Parisot C, Sleilaty G, Deloche A, Fabiani JN. Pheochromocytoma-induced inverted Takotsubo cardiomyopathy: a case of patient resuscitation with extracorporeal life support. J Thorac Cardiovasc Surg 2008;135:434–5
34. de Souza F, Altenburg Odebrecht Curi Gismondi R, Henriques Cunha Neto S, de Mattos MA. Tako-tsubo-like cardiomyopathy and extra-adrenal pheochromocytoma: case report and literature review. Clin Res Cardiol 2008;97:397–401
35. Kim HS, Chang WI, Kim YC, Yi SY, Kil JS, Hahn JY, Kang M, Lee MS, Lee SH. Catecholamine cardiomyopathy associated with paraganglioma rescued by percutaneous cardiopulmonary support: inverted Takotsubo contractile pattern. Circ J 2007;71:1993–5
36. Sanchez-Recalde A, Costero O, Oliver JM, Iborra C, Ruiz E, Sobrino JA. Images in cardiovascular medicine. Pheochromocytoma-related cardiomyopathy: inverted Takotsubo contractile pattern. Circulation 2006;113:e738–e739
37. Spes C, Knape A, Mudra H. Recurrent tako-tsubo-like left ventricular dysfunction (apical ballooning) in a patient with pheochromocytoma—a case report. Clin Res Cardiol 2006;95:307–11
38. Haghi D, Fluechter S, Suselbeck T, Saur J, Bheleel O, Borggrefe M, Papavassiliu T. Takotsubo cardiomyopathy (acute left ventricular apical ballooning syndrome) occurring in the intensive care unit. Intensive Care Med 2006;32:1069–74
39. Park JH, Kang SJ, Song JK, Kim HK, Lim CM, Kang DH, Koh Y. Left ventricular apical ballooning due to severe physical stress in patients admitted to the medical ICU. Chest 2005;128:296–302
40. Coons JC, Barnes M, Kusick K. Takotsubo cardiomyopathy. Am J Health Syst Pharm 2009;15:66:562–6
41. Gianni M, Dentali F, Grandi AM, Sumner G, Hiralal R, Lonn E. Apical ballooning syndrome or takotsubo cardiomyopathy: a systematic review. Eur Heart J 2006;27:1523–9
42. Aurigemma GP, Tighe DA. Echocardiography and reversible left ventricular dysfunction. Am J Med 2006;119:18–21
43. Donohue D, Movahed MR. Clinical characteristics, demographics and prognosis of transient left ventricular apical ballooning syndrome. Heart Fail Rev 2005;10:311–6
44. Bybee KA, Kara T, Prasad A, Lerman A, Barsness GW, Wright RS, Rihal CS. Systematic review: transient left ventricular apical ballooning: a syndrome that mimics ST-segment elevation myocardial infarction. Ann Intern Med 2004;141:858–65
45. Reeder GS, Prasad A. Stress induced (Takotsubo) cardiomyopathy. Version 17.3, September 2009 UpToDate. Available at: www.uptodate.com. Accessed January 13, 2010
46. Tarkin JM, Khetyar M, Kaski JC. Management of Tako-tsubo syndrome. Cardiovasc Drugs Ther 2008;22:71–7
47. Brenner ZR, Powers J. Takotsubo cardiomyopathy. Heart Lung 2008;37:1–7
48. Prasad A, Lerman A, Rihal CS. Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction. Am Heart J 2008;155:408–17
49. Vizzardi E, D'Aloia A, Zanini G, Fiorina C, Chiari E, Nodari S, Dei Cas L. Tako-tsubo-like left ventricular dysfunction: transient left ventricular apical ballooning syndrome. Int J Clin Pract. Epub ahead of print, September 17, 2008
50. Sealove BA, Tiyyagura S, Fuster V. Takotsubo cardiomyopathy. J Gen Intern Med 2008;23:1904–8
51. Nef HM, Möllmann H, Elsässer A. Tako-tsubo cardiomyopathy (apical ballooning). Heart 2007;93:1309–15
52. Buchholz S, Rudan G. Tako-tsubo syndrome on the rise: a review of the current literature. Postgrad Med J 2007;83:261–4
53. Grawe H, Katoh M, Kuhl HP. Stress cardiomyopathy mimicking acute coronary syndrome: case presentation and review of the literature. Clin Res Cardiol 2006;95:179–85
54. Ako J, Sudhir K, Farouque O, Honda Y, Fitzgerald PJ. Transient left ventricular dysfunction under severe stress: brain-heart relationship revisited [Review]. Am J Med 2006;119:10–15
55. Desmet W. Dynamic LV obstruction in apical ballooning syndrome: the chicken or the egg. Eur J Echocardiogr 2006;7:1–4
56. Connelly K, MacIsaac A, Jelinek MV. The “Tako-tsubo” phenomenon and myocardial infarction [Editorial]. South Med J 2006;99:2–3
57. Dec GW. Recognition of the apical ballooning syndrome in the United States. Circulation 2005;111:388–90
58. Hessel EA. The brain and the heart. Anesth Analg 2006;103:522–6
59. Regnante RA, Zuzek RW, Weinsier SB, Latif SR, Linsky RA, Ahmed HN, Sadiq I. Clinical characteristics and four-year outcomes of patients in the Rhode Island Takotsubo Cardiomyopathy Registry. Am J Card 2009;103:1015–9
60. Singh NK, Rumman S, Mikell FL, Nallamothu N, Rangaswamy C. Stress cardiomyopathy: clinical and ventriculographic characteristics in 107 North American subjects. Int J Cardiol. Epub ahead of print, January 18, 2009
61. von Korn H, Yu J, Lotze U, Ohlow MA, Huegl B, Schulte W, Haberl K, Wagner A, Gruene S, Lauer B. Tako-Tsubo-like cardiomyopathy: specific ECG findings, characterization and clinical findings in a European single center. Cardiology 2009;112:42–8
62. Valbusa A, Abbadessa F, Giachero C, Vischi M, Zingarelli A, Olivieri R, Visconti LO. Long-term follow-up of Tako-Tsubo-like syndrome: a retrospective study of 22 cases. J Cardiovasc Med (Hagerstown) 2008;9:805–9
63. Bonello L, Com O, Ait-Moktar O, Théron A, Moro PJ, Salem A, Sbragia P, Paganelli F. Ventricular arrhythmias during Tako-tsubo syndrome. Int J Cardiol 2008;128:e50–e53
64. El Mahmoud R, Mansencal N, Pilliére R, Leyer F, Abbou N, Michaud P, Nallet O, Digne F, Lacombe P, Cattan S, Dubourg O. Prevalence and characteristics of left ventricular outflow tract obstruction in Tako-Tsubo syndrome. Am Heart J 2008;156:543–8
65. Sharkey SW, Lesser JR, Menon M, Parpart M, Maron MS, Maron BJ. Spectrum and significance of electrocardiographic patterns, troponin levels, and thrombolysis in myocardial infarction frame count in patients with stress (Tako-tsubo) cardiomyopathy and comparison to those in patients with ST-elevation anterior wall myocardial infarction. Am J Cardiol 2008;15:101:1723–8
66. Elian D, Osherov A, Matetzky S, Hod H, Guetta V, Feinberg MS, Di Segni E. Left ventricular apical ballooning: not an uncommon variant of acute myocardial infarction in women. Clin Cardiol 2006;29:9–12
67. Elesber AA, Prasad A, Lennon RJ, Wright RS, Lerman A, Rihal CS. Four-year recurrence rate and prognosis of the apical ballooning syndrome. J Am Coll Cardiol 2007;50:448–52
68. Kurowski V, Kaiser A, von Hof K, Killermann DP, Mayer B, Hartmann F, Schunkert H, Radke PW. Apical and midventricular transient left ventricular dysfunction syndrome (tako-tsubo cardiomyopathy): frequency, mechanisms, and prognosis. Chest 2007;132:809–16
69. Athanasiadis A, Vogelsberg H, Hauer B, Meinhardt G, Hill S, Sechtem U. Transient left ventricular dysfunction with apical ballooning (tako-tsubo cardiomyopathy) in Germany. Clin Res Cardiol 2006;95:321–8
70. Hertting K, Krause K, Harle T, Boczor S, Reimers J, Kuck KH. Transient left ventricular apical ballooning in a community hospital in Germany. Int J Cardiol 2006;112:282–8
71. Sharkey SW, Lesser JR, Zenovich AG, Maron MS, Lindberg J, Longe TF, Maron BJ. Acute and reversible cardiomyopathy provoked by stress in women from the United States. Circulation 2005;111:472–9
72. Wittstein IS, Thiemann DR, Lima JA, Baughman KL, Schulman SP, Gerstenblith G, Wu KC, Rade JJ, Bivalacqua TJ, Champion HC. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 2005;352:539–48
73. Kurisu S, Sato H, Kawagoe T, Ishihara M, Shimatani Y, Nishioka K, Kono Y, Umemura T, Nakamura S. Tako-tsubo-like left ventricular dysfunction with ST-segment elevation: a novel cardiac syndrome mimicking acute myocardial infarction. Am Heart J 2002;143:448–55
74. Tsuchihashi K, Ueshima K, Uchida T, Oh-mura N, Kimura K, Owa M, Yoshiyama M, Miyazaki S, Haze K, Ogawa H, Honda T, Hase M, Kai R, Morii I; for the Angina Pectoris-Myocardial Infarction Investigations in Japan. Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction. J Am Coll Cardiol 2001;38:11–18
75. Jiang JP, Downing SE. Catecholamine cardiomyopathy: review and analysis of pathogenetic mechanisms. Yale J Biol Med 1990;63:581–91
76. Litvinov IV, Kotowycz MA, Wassmann S. Iatrogenic epinephrine-induced reverse Takotsubo cardiomyopathy: direct evidence supporting the role of catecholamines in the pathophysiology of the “broken heart syndrome”. Clin Res Cardiol 2009;98:457–62
77. Abraham J, Mudd, JO, Kapur N, Klein K, Champion HC, Wittstein IS. Stress cardiomyopathy after intravenous administration of catecholamines and beta-receptor agonists. J Am Coll Cardiol 2009;53:1320–5
78. Izumi Y, Okatani H, Shiota M, Nakao T, Ise R, Kito G, Miura K, Iwao H. Effects of metoprolol on epinephrine-induced takotsubo-like left ventricular dysfunction in non-human primates. Hypertens Res 2009;32:339–46
79. Budhwani N, Bonaparte KL, Cuyjet AB, Saric M. Severe reversible left ventricular systolic and diastolic dysfunction due to accidental iatrogenic epinephrine overdose. Rev Cardiovasc Med 2004;5:130–3
80. Meaudre E, Barbou F, Sallaberry M, Cantais E, Petit D, Palmier B. Rapid reversal of global left ventricular dysfunction after accidental injection of 0.75 mg epinephrine in a 20-year-old patient. Acta Anaesthesiol Scand 2004;48:914–6
81. Sato Y, Tanaka M, Nishikawa T. Reversible catecholamine-induced cardiomyopathy by subcutaneous injections of epinephrine solution in an anesthetized patient. Anesthesiology 2000;92:615–9
82. Suk EH, Kim DH, Kweon TD, Na SW, Shin JA. Stress-induced cardiomyopathy following cephalosporin-induced anaphylactic shock during general anesthesia. Can J Anaesth 2009;56:432–6
83. Zubrinich CM, Omar Farouque HM, Rochford SE, Sutherland MF. Tako-tsubo-like cardiomyopathy after EpiPen administration. Intern Med J 2008;38:862–5
84. Han Y, Yeon S. Midventricular hypokinesis as a cardiac manifestation of anaphylaxis: a case report. J Am Soc Echocardiogr 2006;1529.e9–1529.e11
85. Vultaggio A, Matucci A, Del Pace S, Simonetti I, Parronchi P, Rossi O, Maggi E, Gensini G, Romagnani S. Tako-Tsubo-like syndrome during anaphylactic reaction. Eur J Heart Fail 2007;9:209–11
86. Devereaux PJ, Goldman L, Yusuf S, Gilbert K, Leslie K, Guyatt GH. Surveillance and prevention of major perioperative ischemic cardiac events in patients undergoing noncardiac surgery: a review. CMAJ 2005;173:779–88
87. Pezzo SP, Hartlage G, Edwards CM. Takotsubo cardiomyopathy presenting with dyspnea. J Hosp Med 2009;4:200–2
88. Patel HM, Kantharia BK, Morris DL, Yazdanfar S. Takotsubo syndrome in African-American women with atypical presentations: a single-center experience. Clin Cardiol 2007;30:14–18
89. Denney SD, Lakkireddy DR, Khan IA. Long QT syndrome and torsade de pointes in transient left ventricular apical ballooning syndrome. Int J Cardiol 2005;100:499–501
90. Zaroff JG, Pawlikowska L, Miss JC, Yarlagadda S, Ha C, Achrol A, Kwok PY, McCulloch CE, Lawton MT, Ko N, Smith W, Young WL. Adrenoceptor polymorphisms and the risk of cardiac injury and dysfunction after subarachnoid hemorrhage. Stroke 2006;37:1680–5
91. Rochais F, Vilardaga JP, Nikolaev VO, Bünemann M, Lohse MJ, Englelhardt S. Real-time optical recording of beta1-adrenergic receptor activation reveals supersensitivity of the Arg389 variant to carvedilol. J Clin Invest 2007;117:229–35
92. DeGeorge BR Jr, Koch WJ. Beta blocker specificity: a building block toward personalized medicine. J Clin Invest 2007;117:86–9
93. Sharkey SW, Maron BJ, Nelson P, Parpart M, Maron MS, Bristow MR. Adrenergic receptor polymorphisms in patients with stress (tako-tsubo) cardiomyopathy. J Cardiol 2009;53:53–7
94. Dandel M, Lehmkuhl HB, Schmidt G, Knosalla C, Hetzer R. Striking observations during emergency catecholamine treatment of cardiac syncope in a patient with initially unrecognized Takotsubo cardiomyopathy. Circ J 2009;73:1543–6
95. Padayachee L. Levosimendan: the inotrope of choice in cardiogenic shock secondary to takotsubo cardiomyopathy? Heart Lung Circ 2007;16(suppl 3):S65–S70
96. Chen ZM, Pan HC, Chen YP, Peto R, Collins R, Jiang LX, Xie JX, Liu LS; COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005;366: 1622–32
97. Jefic D, Koul D, Boguszewski A, Martini W. Transient left ventricular apical ballooning syndrome caused by abrupt metoprolol withdrawal. Int J Cardiol 2008;131:e35–e37
98. Lee VH, Oh JK, Mulvagh SL, Wijdicks EF. Mechanisms in neurogenic stress cardiomyopathy after aneurysmal subarachnoid hemorrhage. Neurocrit Care 2006;5:243–9

**Multiple terms have been used to refer to this entity, and its confusing taxonomy has been discussed by Wittstein.2 Similarly, the diagnostic criteria continue to evolve.3 In this editorial, we have chosen to use the term “takotsubo cardiomyopathy” because of its familiarity and ubiquitous presence in the literature even though many cases do not show the classic takotsubo pattern of wall motion abnormalities (apical ballooning), which refer to the “octopus pot” shape (“takotsubo” in Japanese).
Cited Here...

††The novice to this syndrome may find this Web site enlightening: http://www.takotsubo.com.
Cited Here...

© 2010 International Anesthesia Research Society